Coloplast ASColoplast ASColoplast AS

Coloplast AS

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪26.47 B‬USD
3.38USD
‪753.93 M‬USD
‪4.03 B‬USD
‪142.07 M‬
Beta (1Y)
0.38
Employees (FY)
‪16.64 K‬
Change (1Y)
+947 +6.03%
Revenue / Employee (1Y)
‪242.43 K‬USD
Net income / Employee (1Y)
‪45.31 K‬USD

About COLOPLAST B A/S


CEO
Kristian Villumsen
Headquarters
Humlebaek
Founded
1957
ISIN
DK0060448595
FIGI
BBG000BMB5X8
Coloplast A/S engages in the developing, manufacture, and markets medical products. It operates through the following segments: Chronic Care, Voice and Respiratory Care, Interventional Urology, Advanced Wound Dressings, and Biologics. The Chronic Care segment covers the sale of ostomy care products and continence care products. The Voice and Respiratory Care segment refers to the sale of laryngectomy and tracheostomy products. The Interventional Urology segment includes the sale of urological products, including disposable products. The Advanced Wound Dressings segment focuses on the sale of wound and skin care products. The Biologics segment represents a new segment covering the sale of tissue-based products. The company was founded by Aage Louis-Hansen and Johanne Louise-Hansen in 1954 and is headquartered in Humlebaek, Denmark.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
C
XS248128852
COLOPL. FIN. 22/30 MTN
Yield to maturity
3.07%
Maturity date
May 19, 2030
C
XS248128780
COLOPL. FIN. 22/27 MTN
Yield to maturity
2.68%
Maturity date
May 19, 2027

Explore more bonds 

Frequently Asked Questions


The current price of CLPBF is 112.54 USD — it has decreased by −1.19% in the past 24 hours. Watch Coloplast AS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Coloplast AS stocks are traded under the ticker CLPBF.
CLPBF stock has fallen by −6.24% compared to the previous week, the month change is a −11.78% fall, over the last year Coloplast AS has showed a −1.59% decrease.
We've gathered analysts' opinions on Coloplast AS future price: according to them, CLPBF price has a max estimate of 145.12 USD and a min estimate of 98.63 USD. Watch CLPBF chart and read a more detailed Coloplast AS stock forecast: see what analysts think of Coloplast AS and suggest that you do with its stocks.
CLPBF reached its all-time high on Nov 2, 2012 with the price of 217.80 USD, and its all-time low was 49.00 USD and was reached on Dec 26, 2012. View more price dynamics on CLPBF chart.
See other stocks reaching their highest and lowest prices.
CLPBF stock is 0.97% volatile and has beta coefficient of 0.38. Track Coloplast AS stock price on the chart and check out the list of the most volatile stocks — is Coloplast AS there?
Today Coloplast AS has the market capitalization of ‪26.03 B‬, it has decreased by −5.17% over the last week.
Yes, you can track Coloplast AS financials in yearly and quarterly reports right on TradingView.
Coloplast AS is going to release the next earnings report on Feb 4, 2025. Keep track of upcoming events with our Earnings Calendar.
CLPBF earnings for the last quarter are 0.82 USD per share, whereas the estimation was 0.86 USD resulting in a −5.06% surprise. The estimated earnings for the next quarter are 0.84 USD per share. See more details about Coloplast AS earnings.
Coloplast AS revenue for the last quarter amounts to ‪1.04 B‬ USD, despite the estimated figure of ‪1.03 B‬ USD. In the next quarter, revenue is expected to reach ‪984.34 M‬ USD.
CLPBF net income for the last quarter is ‪196.09 M‬ USD, while the quarter before that showed ‪182.56 M‬ USD of net income which accounts for 7.41% change. Track more Coloplast AS financial stats to get the full picture.
Coloplast AS dividend yield was 2.51% in 2024, and payout ratio reached 97.94%. The year before the numbers were 2.81% and 94.57% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 13, 2024, the company has ‪16.64 K‬ employees. See our rating of the largest employees — is Coloplast AS on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Coloplast AS EBITDA is ‪1.30 B‬ USD, and current EBITDA margin is 32.19%. See more stats in Coloplast AS financial statements.
Like other stocks, CLPBF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Coloplast AS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Coloplast AS technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Coloplast AS stock shows the strong sell signal. See more of Coloplast AS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.